Axonics did not infringe Medtronic's patents, jury rules [Yahoo! Finance]
Axonics, Inc. (AXNX)
Last axonics, inc. earnings: 3/4 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
after Medtronic alleged the company had copied three elements of its sacral neuromodulation technology. The lawsuit brought before the US Court for California's Central District by Medtronic in 2019 sought to prove that Axonics had infringed three technical elements individually patented within the Medtronic's InterStim device. The suit argued that Axonics' sacral neuromodulation systems, known as r-SNM, infringed US patents No. 8036756, No. 8626314, and No. 9463324, all of which pertain to the charging, temperature control, and wiring system within the device. Axonics announced that the first commercial implants of the Axonics rSNM System in the United States took place on October 29, 2019. A full jury trial before the US courts cleared Axionics, finding that the company did not infringe on any of Medtronic's patents by way of the technology being deemed obvious. In the verdict sheet issued by the court Medtronic failed to adequately prove its claims. Speaking following the v
Show less
Read more
Impact Snapshot
Event Time:
AXNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXNX alerts
High impacting Axonics, Inc. news events
Weekly update
A roundup of the hottest topics
AXNX
News
- Axonics Prevails in Patent Infringement Lawsuit with Medtronic [Yahoo! Finance]Yahoo! Finance
- Axonics Prevails in Patent Infringement Lawsuit with MedtronicBusiness Wire
- Axonics gains after win in trial in patent dispute with Medtronic [Seeking Alpha]Seeking Alpha
- Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Axonics Modulation Technologies (AXNX) Surpasses Q2 Earnings and Revenue Estimates [Yahoo! Finance]Yahoo! Finance
AXNX
Earnings
- 8/1/24 - Beat
AXNX
Sec Filings
- 8/1/24 - Form 10-Q
- 8/1/24 - Form 8-K
- 7/25/24 - Form 4
- AXNX's page on the SEC website